Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480. (Q34358809)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480. |
scientific article |
Statements
1 reference
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480. (English)
1 reference
Cancer and Leukemia Group B
1 reference
George Wilding
1 reference
Jimmie C Holland
1 reference
Mark J Ratain
1 reference
Tim A Ahles
1 reference
James E Herndon
1 reference
Eric J Small
1 reference
Nicholas J Vogelzang
1 reference
Alice B Kornblith
1 reference
Walter Stadler
1 reference
David Palchak
1 reference
M Ernest Marshall
1 reference
Daniel Petrylak
1 reference
1 November 2004
1 reference
Identifiers
1 reference